Numerous studies have shown that CPT2 is oncogenic in hepatocellular carcinoma, colorectal carcinoma, renal clear cell carcinoma, and primary ovarian plasmacytoid carcinoma, and is associated with proliferation, migration, invasion, stemness, apoptosis, and chemo-resistance of cancer cells [125,126,127]. This evidence concerns the gene CPT2 and cancer.